Dr Ross Camidge is the Director of the Thoracic Oncology Clinical Program at the University of Colorado in Aurora, USA.
His focus is in thoracic malignancies and developmental therapeutics, and is dual-trained in both medical oncology and clinical pharmacology.
He is the National Medical Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and a member of the National Comprehensive Cancer Network Lung Cancer Committee.
As well as being a principal investigator on numerous clinical trials in early phase drug development and thoracic malignancies, he has authored more than 150 articles in peer-reviewed journals and presented his research at multiple national and international scientific meetings.